Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universitaet, Pettenkoferstrasse 9, D-80336 Muenchen, Germany.
J Pharmacol Exp Ther. 2013 Jan;344(1):85-95. doi: 10.1124/jpet.112.199190. Epub 2012 Oct 18.
The DRY motif with the highly conserved R3.50 is a hallmark of family A G protein-coupled receptors (GPCRs). The crystal structure of rhodopsin revealed a salt bridge between R135(3.50) and another conserved residue, E247(6.30), in helix 6. This ionic lock was shown to maintain rhodopsin in its inactive state. Thus far, little information is available on how interruption of this ionic bond affects signaling properties of nonrhodopsin GPCRs, because the focus has been on mutations of R3.50, although this residue is indispensable for G protein activation. To investigate the importance of an ionic lock for overall receptor activity in a nonrhodopsin GPCR, we mutated R128(3.50) and E238(6.30) in the bradykinin (BK) B(2) receptor (B(2)R) and stably expressed the constructs in HEK293 cells. As expected, mutation of R3.50 resulted in lack of G protein activation. In addition, this mutation led to considerable constitutive receptor internalization. Mutation of E6.30 (mutants E6.30A and E6.30R) also caused strong constitutive internalization. Most intriguingly, however, although the two E6.30 mutants displayed no increased basal phosphatidylinositol hydrolysis, they gave a response to three different B(2)R antagonists that was almost comparable to that obtained with BK. In contrast, swapping of R3.50 and E6.30, thus allowing the formation of an inverse ionic bond, resulted in rescue of the wild type phenotype. These findings demonstrate for the first time, to our knowledge, that interruption of the ionic lock in a family A GPCR can have distinctly different effects on receptor internalization and G protein stimulation, shedding new light on its role in the activation process.
DRY 基序与高度保守的 R3.50 是家族 A G 蛋白偶联受体 (GPCR) 的标志。视紫红质的晶体结构揭示了 6 螺旋中 R135(3.50)和另一个保守残基 E247(6.30)之间的盐桥。这种离子键被证明可以使视紫红质保持在非活性状态。到目前为止,关于这种离子键的中断如何影响非视紫红质 GPCR 的信号转导特性,我们所了解的信息很少,因为人们一直关注 R3.50 的突变,尽管该残基对于 G 蛋白的激活是不可或缺的。为了研究离子键对非视紫红质 GPCR 整体受体活性的重要性,我们在缓激肽 (BK) B(2) 受体 (B(2)R) 中突变了 R128(3.50)和 E238(6.30),并在 HEK293 细胞中稳定表达了这些构建体。正如预期的那样,R3.50 的突变导致 G 蛋白激活的缺失。此外,这种突变导致受体的大量组成型内化。E6.30 的突变 (E6.30A 和 E6.30R 突变体) 也导致强烈的组成型内化。然而,最有趣的是,尽管这两个 E6.30 突变体没有增加基础磷脂酰肌醇水解,但它们对三种不同的 B(2)R 拮抗剂的反应几乎与 BK 获得的反应相当。相比之下,R3.50 和 E6.30 的交换,从而允许形成反向离子键,导致挽救了野生型表型。这些发现首次证明,在我们的知识范围内,家族 A GPCR 中离子键的中断可以对受体内化和 G 蛋白刺激产生明显不同的影响,为其在激活过程中的作用提供了新的认识。